| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.14 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.61 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |